Related Experiment Video
Updated: Apr 10, 2026
08:51
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
2.3K
Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space
1Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.
Computational and Mathematical Methods in Medicine
|June 17, 2015
Summary
This study introduces a new computational method using matrix factorization and genomic data to predict new uses for existing drugs, reducing drug development costs. The approach effectively leverages gene interaction networks to uncover novel drug-disease associations.
Area of Science:
- Bioinformatics
- Computational Biology
- Pharmacogenomics
Background:
- High costs of new drug development necessitate novel drug indication discovery.
- Existing computational methods often overlook valuable interaction data.
- Drug repurposing is a cost-effective strategy for identifying new therapeutic uses.
Purpose of the Study:
- To develop a novel computational framework for predicting drug-disease associations.
- To integrate genomic information into drug indication prediction models.
- To identify potential novel therapeutic uses for existing drugs.
Main Methods:
- A matrix factorization model was developed using known drug-disease associations.
- Genomic space, including drug-gene, disease-gene, and gene-gene interactions, was integrated.
- Feature vectors for drugs, diseases, and genes were derived from interaction data.
Main Results:
- The integration of genomic space significantly improved the prediction of drug-disease associations.
- The matrix factorization model effectively quantified associations between drugs and diseases.
- Experimental validation demonstrated the efficacy of the proposed framework.
Conclusions:
- Leveraging interaction data and genomic information is crucial for accurate drug indication prediction.
- The proposed matrix factorization model offers a promising approach for drug repurposing.
- This method can accelerate the discovery of novel therapeutic applications for drugs.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
91
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
91
01:21Factors Affecting Drug Response: Overview
3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
01:29Pharmacogenetics and Pharmacogenomics: Overview
171
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
171
01:27Pharmacogenetics of Drug Metabolism: Overview
147
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
147
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
122
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
122
01:18Factors Affecting Protein-Drug Binding: Drug-Related Factors
643
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
643